Association of glutathione S-transferase M1 and T1 null polymorphisms with the development of cervical lesions: a meta-analysis
- PMID: 21962942
- DOI: 10.1016/j.ejogrb.2011.09.012
Association of glutathione S-transferase M1 and T1 null polymorphisms with the development of cervical lesions: a meta-analysis
Abstract
Objectives: An accumulation of evidence suggests that gene-based self-susceptibility may contribute to the development of cancer. Some studies have found that particular polymorphisms of the glutathione S-transferase M1 and T1 genes are associated with increased risk of cervical lesions, but other studies have had contrary results. The present meta-analysis evaluated the association of glutathione S-transferase M1 and T1 null polymorphisms with the development of cervical lesions. In addition, stratified analyses were performed in an attempt to identify any race-specific effects.
Study design: Twenty-one related studies were included in the meta-analysis, comprising glutathione S-transferase M1 data from 1423 patients with cervical lesions and 2415 healthy matched controls, and glutathione S-transferase T1 data from 2081 patients with cervical lesions and 2287 healthy matched controls. The fixed-effect model (Mantel-Haenszel method) and the random-effect (DerSimonian and Laird) model were used to examine the difference in frequency of glutathione S-transferase M1 and T1 null polymorphisms between pre- and invasive cervical lesions. Subgroup analyses were also conducted to evaluate any race-specific effect on the frequencies of glutathione S-transferase polymorphisms in cervical lesions. Odds ratios (OR) and 95% confidence intervals (CI) were calculated. Heterogeneity was assessed using the heterogeneity metric (I²) and Chi-squared test.
Results: The glutathione S-transferase M1 null polymorphism was associated with increased risk of low-grade intra-epithelial lesions (OR 1.37, 95% CI 1.05-1.77), but no increased risk of high-grade intra-epithelial lesions (OR 1.29, 95% CI 0.87-1.8) or invasive cervical cancer (OR 1.20, 95% CI 0.99-1.46). The association seemed to be confined to Southeast Asians (OR 1.97, 95% CI 1.44-2.71). No significant associations were found for the glutathione S-transferase T1 null polymorphism for any of the populations.
Conclusions: The glutathione S-transferase M1 null polymorphism significantly increases susceptibility to early-stage cervical lesions in Southeast Asians. However, the glutathione S-transferase T1 null polymorphism does not appear to be a risk factor for cervical lesions in any population.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Glutathione-S-transferase M1 and T1 and cytochrome P1A1 genetic polymorphisms and susceptibility to cervical intraepithelial neoplasia in Greek women.Eur J Cancer Prev. 2007 Dec;16(6):498-504. doi: 10.1097/01.cej.0000243859.99265.92. Eur J Cancer Prev. 2007. PMID: 18090121
-
Glutathione S-transferase M1 and T1 polymorphisms and cervical cancer risk: a meta-analysis.Neoplasma. 2011;58(4):352-9. doi: 10.4149/neo_2011_04_352. Neoplasma. 2011. PMID: 21520994
-
Does occupational exposure to solvents and pesticides in association with glutathione S-transferase A1, M1, P1, and T1 polymorphisms increase the risk of bladder cancer? The Belgrade case-control study.PLoS One. 2014 Jun 10;9(6):e99448. doi: 10.1371/journal.pone.0099448. eCollection 2014. PLoS One. 2014. PMID: 24914957 Free PMC article.
-
Lack of association between glutathione S-transferase M1 and T1 gene polymorphisms and susceptibility to preeclampsia: An updated systematic review and meta-analysis.Am J Reprod Immunol. 2020 Dec;84(6):e13303. doi: 10.1111/aji.13303. Epub 2020 Aug 1. Am J Reprod Immunol. 2020. PMID: 32658338
-
Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: a HuGE review and meta-analysis.Am J Epidemiol. 2011 Apr 15;173(8):847-57. doi: 10.1093/aje/kwq480. Epub 2011 Mar 24. Am J Epidemiol. 2011. PMID: 21436184 Review.
Cited by
-
CD95 rs1800682 polymorphism and cervical cancer risk: evidence from a meta-analysis.Tumour Biol. 2014 Mar;35(3):1785-90. doi: 10.1007/s13277-013-1237-6. Epub 2013 Oct 11. Tumour Biol. 2014. PMID: 24114012
-
Individual effects of GSTM1 and GSTT1 polymorphisms on cervical or ovarian cancer risk: An updated meta-analysis.Front Genet. 2023 Jan 12;13:1074570. doi: 10.3389/fgene.2022.1074570. eCollection 2022. Front Genet. 2023. PMID: 36712849 Free PMC article.
-
Glutathione S-transferase polymorphisms (GSTM1, GSTT1 and GSTP1) and their susceptibility to renal cell carcinoma: an evidence-based meta-analysis.PLoS One. 2013 May 22;8(5):e63827. doi: 10.1371/journal.pone.0063827. Print 2013. PLoS One. 2013. PMID: 23717494 Free PMC article.
-
Contribution of GSTM1, GSTT1, and MTHFR polymorphisms to end-stage renal disease of unknown etiology in Mexicans.Indian J Nephrol. 2013 Nov;23(6):438-43. doi: 10.4103/0971-4065.120342. Indian J Nephrol. 2013. PMID: 24339523 Free PMC article.